Use of a Novel Drug in People With Non-alcoholic Steatohepatitis (NASH) or Non-alcoholic Fatty Liver Disease (NAFLD)

Clinical trial NCT02605616 · TERMINATED

Trial details

NCT number: NCT02605616
Sponsor: University of Alabama at Birmingham
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-alcoholic Fatty Liver Disease (NAFLD)Non-alcoholic Steatohepatitis (NASH)

Start date: 2015-11-01
Primary completion: 2019-09-01
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.